Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites
ConclusionsApproximately half of patients with cirrhosis and ascites use PPI. This use increases their risk of bacterial infections, but does not affect their prognosis after an infection occurs.This article is protected by copyright. All rights reserved.
Source: Liver International - Category: Gastroenterology Authors: Gitte Dam,
Hendrik Vilstrup,
Per Kragh Andersen,
Lars Bossen,
Hugh Watson,
Peter Jepsen Tags: Original Article Source Type: research
More News: Bleeding | Cirrhosis | Gastroenterology | Liver | Peritonitis | Respiratory Medicine | Urology & Nephrology